Name | Value |
---|---|
Revenues | 5,472.9K |
Cost of Revenue | 4,242.4K |
Gross Profit | 1,230.5K |
Operating Expense | 2,617.1K |
Operating I/L | -1,386.6K |
Other Income/Expense | -143.7K |
Interest Income | 13.3K |
Pretax | -1,530.3K |
Income Tax Expense | 1.3K |
Net Income/Loss | -1,531.6K |
ImmuCell Corporation is an animal health company that develops, manufactures, and markets products to enhance the health and productivity of dairy and beef cattle. Its product line includes First Defense, a scours preventive product for newborn calves, Tri-Shield First Defense for the treatment of E. coli, coronavirus, and rotavirus, and the California Mastitis Test for detecting somatic cell counts in milk. The company also offers Dual-Force First Defense for the nutritional and feed supplement markets and is involved in developing Re-Tain, an intramammary treatment for subclinical mastitis in lactating dairy cows. ImmuCell sells its products through animal health distributors.